Plain-English translation of NCT07648823 on ClinicalTrials.gov ↗ · Source last updated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
China
Phase
Safety & dosing
Sponsor
Beijing Tiantan Hospital
Enrollment target
~5 participants
Started
June 2026
Primary completion
June 2027
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Li'ao Wang, M.D.
Beijing Tiantan Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.